Stocknear Logo Stocknear
/
Popular
Login

Taysha Gene Therapies Inc...

1.20
-0.07 (-5.51%)
At close: Apr 16, 2025, 10:35 AM

Taysha Gene Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
-89.3M -111.57M -166.01M -174.52M -60.01M -4.46M
1.25M 1.37M 1.17M 492K 9K n/a
13.1M 7.91M 18.04M 18.18M 3.35M n/a
-9.55M -15.72M 26.32M 14.17M -2.07M 540K
6.19M 47.28M 39.89M 10.14M 26.03M 3.92M
n/a n/a n/a n/a n/a n/a
-12.47M -18.01M 18.52M 28.67M -111K 540K
-81.22M -73.02M -88.39M -117.04M -30.73M 135K
-374K -7.37M -24.87M -21.55M -9.08M n/a
n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a
11K -3.48M -61K -6.25M -9M n/a
-363K -7.35M -24.93M -21.55M -9.08M n/a
n/a -3.45M n/a 39.96M n/a n/a
n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a
-96K -628K -1.15M -874K n/a n/a
76.68M 136.39M 52.1M 39.08M 291.06M n/a
-4.9M 56.02M -61.22M -99.51M 251.25M 135K
-81.6M -80.39M -113.26M -138.6M -39.81M 135K

Create Price Alert on TSHA

Your price alert will notify you when the stock price is above 1.2.

Add to Watchlist